CDKN2A and uterine cervix carcinoma in situ: Overexpression of p16 was seen in 70% (70/100) of cases and test of proportion showed that overexpression was significantly higher in CIN I and CIN II (CIN I – 72.22%, CIN II – 83.33%) but decreased in CIN III (62.16%) (Figure 2).